Pfizer - Guiding light: Practical perspectives of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer

Navigating through clinical trial- and real world-based evidence (ID 152)

Lecture Time
19:30 - 19:30
Session Name
Pfizer - Guiding light: Practical perspectives of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer
Room
Hamburg Hall
Date
Fri, 12.05.2023
Time
18:30 - 19:30
Speakers
  • Richard S. Finn (Los Angeles, CA, United States of America)
Authors
  • Richard S. Finn (Los Angeles, CA, United States of America)